Bios Equity Partners II, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 244,025 shares at $4.85 ($1.1M) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Open-market sale of $1.1M LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.40 | 4,649 | $20K | 1.8% |
| 2 | $4.40 | 10,620 | $47K | 4.1% |
| 3 | $4.40 | 34,731 | $153K | 13.3% |
| 4 | $4.40 | 34,731 | $153K | 13.3% |
| 5 | $4.85 | 6,909 | $34K | 2.9% |
| 6 | $4.85 | 15,780 |
| $77K |
| 6.7% |
| 7 | $4.85 | 51,608 | $250K | 21.8% |
| 8 | $4.85 | 51,608 | $250K | 21.8% |
| 9 | $4.87 | 1,832 | $9K | 0.8% |
| 10 | $4.87 | 4,185 | $20K | 1.8% |
| 11 | $4.87 | 13,686 | $67K | 5.8% |
| 12 | $4.87 | 13,686 | $67K | 5.8% |
| Total | $4.70 avg | 244,025 | $1.1M | 100% |